MMG Welcomes Ann Kottcamp to Leadership Team
ROCKVILLE, Md., March 8 /PRNewswire/ — MMG (www.wegetpatients.com), a full-service patient recruitment and retention group, today announces the appointment of Ann Kottcamp to vice president/senior strategist of MMG’s central nervous system and mental health therapeutic areas.
“We are extremely pleased that Ann has joined MMG, bringing a unique perspective to our senior leadership team and further deepening our strategic expertise,” said John Benbrook, CEO of MMG. “Ann joins us at an exciting time. We are entering a new era of patient recruitment and retention, and Ann will contribute significantly to MMG leading the industry with excellence and innovation.”
Ann, a veteran in the industry, has more than 15 years’ experience in patient recruitment, most recently serving as president of Argonauta Communications, Inc. Before founding Argonauta Communications, Ann was a driving force at Pharmaceutical Research Plus (PRP). Her experience at PRP included time in project management, client relations, and business development, as well as tenure as CEO. Ann has directed and implemented more than 175 recruitment campaigns across therapeutic areas and is well known in the industry for her acumen and leadership in patient recruitment.
Ann’s passion for research sprang from work she performed under a grant from the National Institute on Drug Abuse (NIDA) at Louisiana State University Medical Center in the department of pharmacology. During this time she co-authored several papers for industry publications. Ann has also conducted preclinical research at the National Institute of Neurological Disorders and Stroke and the National Institute of Mental Health.
MMG, a Ketchum (www.ketchum.com/mmg_news_release) company and part of the Omnicom Group (NYSE: OMC) family, is the premier global patient recruitment and retention organization. With experience in more than 70 countries and across a vast range of therapeutic areas, populations, and study types, MMG provides strategies specially crafted for study teams and patient populations while delivering the best return on investment for the sponsor.
SOURCE Matthews Media Group